Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
How Clinigen Steered Prolacta’s Human Milk-Based Fortifier To Rx Medicine Approval In Japan
Mar 10 2026
•
By
Anju Ghangurde
Human milk–based fortifier gets regulatory recognition as Rx biological product in Japan
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pathways & Standards
More from Pink Sheet